|Articles|February 19, 2021
NIBRT Biosimilar Sequence Variant Assessment & Monitoring
Author(s)Thermo Fisher Scientific
This study demonstrates the use of the workflow for sequence variant assessment and to monitor the variability of product quality attributes in biosimilar when compared to its originator.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
2
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
3
Generative AI and Adaptive Trials Shape Future Biotech Development
4